Concepedia

Publication | Closed Access

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

DOI

133

Citations

20

References

2018

Year

Sònia Pernas, Miguel Martín, Peter A. Kaufman, Marta Gil-Martín, P. Gómez Pardo, Sara López‐Tarruella, Luís Manso, Eva Ciruelos, José Alejandro Pérez Fidalgo, Cristina Hernándo,
The Lancet Oncology

References

YearCitations

Page 1